Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
British Journal of Haematology|September 15, 2009
Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemiaKristie A Blum, Anjani Advani, Louis Fernandez, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
A phase I trial of the novel farnesyl protein transferase inhibitor, BMS-214662, in combination with paclitaxel and carboplatin in patients with advanced cancerGrace K Dy, Laura M Bruzek, Gary A Croghan, et al.The Lancet. Oncology|October 29, 2011
Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trialAnas Younes, Yasuhiro Oki, R Gregory Bociek, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Phase I study of MGCD0103 given as a three-times-per-week oral dose in patients with advanced solid tumorsLillian L Siu, Roberto Pili, Ignacio Duran, et al.British Journal of Haematology|August 3, 2021
Fimepinostat (CUDC-907) in patients with relapsed/refractory diffuse large B cell and high-grade B-cell lymphoma: report of a phase 2 trial and exploratory biomarker analysesDaniel J Landsburg, Stefan K Barta, Radhakrishnan Ramchandren, et al.Blood|May 23, 2008
Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemiaGuillermo Garcia-Manero, Sarit Assouline, Jorge Cortes, et al.Elife|August 30, 2022
Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutationsGaurav S Choudhary, Andrea Pellagatti, Bogos Agianian, et al.Pageof 3